Refractory primary autoimmune myelofibrosis treated with ruxolitinib-Reference-Cited by-同舟云学术

Refractory primary autoimmune myelofibrosis treated with ruxolitinib

Published:2021-05-11 Issue:8 Volume:96 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Otoukesh Salman¹^ORCID,Song Joo Y.²,Mojtahedzadeh Mona³,Mokhtari Sally⁴,Marcucci Guido¹,Pullarkat Vinod¹^ORCID,Ali Haris¹

Affiliation:

1. Department of Hematology and Hematopoietic Cell Transplantation, Gehr Center for Leukemia Research City of Hope National Medical Center California Duarte USA

2. Department of Pathology City of Hope National Medical Center California Duarte USA

3. Division of Psychiatry, Department of Supportive Care Medicine City of Hope National Medical Center California Duarte USA

4. Department of Clinical Translational Project Development City of Hope National Medical Center California Duarte USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26208

Reference9 articles.

1. Primary autoimmune myelofibrosis: Definition of a distinct clinicopathologic syndrome

2. Pathology of Autoimmune Myelofibrosis

3. Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature

4. Increased prevalence of autoimmune phenomena in myelofibrosis: Relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patterns

5. CD8 + T cells and IFN-γ induce autoimmune myelofibrosis in mice

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruxolitinib: a new first-line strategy in autoimmune myelofibrosis treatment;Leukemia & Lymphoma;2023-07-13

2. Improvement in Primary Autoimmune Myelofibrosis Following a Short Course of Steroids and Intravenous Immunoglobulins;Cureus;2022-09-29

3. Coexistence of pancytopenia due to autoimmune myelofibrosis and seizures as presenting complaints in a newly diagnosed case of systemic lupus erythematosus – An interesting combination;Indian Journal of Rheumatology;2022

4. Immunosuppressants;Reactions Weekly;2021-09